Patent · US Active

BCKDK inhibitors

US11059833B2 · kind B2 · utility

1Cited by

0References

23Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Samit Kumar Bhattacharya · Groton, US
Leanne Marie Buzon · Stonington, US
Kevin James Filipski · Reading, US
David A. Griffith · Sudbury, US
Bethany Lyn Kormos · Somerville, US
Luis Angel Martinez-Alsina · Gales Ferry, US
Russell Alan Miller · Dedham, US
Matthew Richard Reese · Mystic, US
Rachel Jane Roth Flach · Rockland, US
Yuan Zhang · Edmond, US

Key dates

Filing date	Oct 23, 2020
Grant date	Jul 13, 2021
Priority date	—
Expiry date	Oct 23, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds of Formula I, wherein R1, R2, and R3 are defined herein, their use as branched-chain alpha keto acid dehydrogenase kinase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetes, NASH and heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.